Claim Denied as Experimental or Investigational: How to Appeal

When an insurer denies a claim by labeling the treatment "experimental" or "investigational," they have determined that the procedure, drug, or device has not been proven safe and effective by their standards. This denial is particularly common for newer cancer treatments, gene therapies, advanced surgical techniques, and off-label drug uses — even when the treatment has significant clinical evidence supporting it and is recommended by your physician. Insurers frequently apply the "experimental" label far more broadly than the evidence warrants, and this is one of the most successfully challenged denial types when the right evidence is assembled.

Why Insurers Deny Claims as Experimental or Investigational

Delayed policy updates. A treatment may gain FDA approval or widespread clinical acceptance months or years before the insurer updates its internal coverage policy. During that gap, claims are denied as experimental even though the treatment has become standard of care. This is particularly common in oncology, where immunotherapies and targeted treatments receive FDA approval at a rapid pace.

Burden-shifting. Labeling a treatment experimental shifts the proof burden to the patient, who must demonstrate that the treatment meets the plan's criteria for coverage. This is a cost-control mechanism, not a genuine evidence assessment.

Small trial populations. For rare diseases, small patient populations mean fewer large-scale randomized controlled trials — even when the treatment is the recognized standard of care for that condition. Insurers exploit this by applying a "not enough evidence" argument even when the existing evidence is the best available for the condition.

Outdated technology assessments. Insurers maintain internal technology assessments that may be years behind current clinical evidence. The NCCN, AHA, and specialty society guidelines may have categorized a treatment as standard of care while the insurer's internal assessment still calls it experimental.

How to Appeal

Step 1: Request the Insurer's Complete Technology Assessment

Request the insurer's complete technology assessment or medical policy for the treatment. This document reveals exactly what criteria the insurer used. Review it carefully for outdated references, missing evidence, or criteria that do not apply to your situation. Under ERISA (29 CFR § 2560.503-1), you are entitled to all documents relevant to the denial.

Step 2: Obtain a Detailed Letter From Your Treating Physician

The letter should explain why the treatment is medically appropriate for your condition, cite the clinical evidence supporting its use, and address the specific criteria the insurer used to deny coverage. Emphasize the physician's credentials and institution — a recognized expert at an academic medical center carries significant weight with both internal reviewers and external IROs.

Step 3: Compile Clinical Evidence

Gather FDA approval documentation, peer-reviewed published studies from respected journals, clinical practice guidelines from NCCN, ASCO, AHA, or the relevant specialty society, and compendium listings. For oncology, NCCN Category 1 recommendations (high-level evidence, uniform consensus) directly contradict an "experimental" classification.

Step 4: Check for State Mandates

Research whether your state requires coverage of the specific treatment or off-label drug use. Over 40 states have laws requiring coverage for certain treatments commonly labeled experimental. Many states mandate coverage for off-label drug use when the drug is recognized in standard medical compendia — the NCCN Drugs and Biologics Compendium, Micromedex DrugDex, or the American Hospital Formulary Service. The ACA (42 USC 300gg-8) requires coverage of routine costs in qualifying clinical trials.

Step 5: File the Internal Appeal Within 180 Days

Clearly state that the treatment meets the plan's criteria for coverage and provide specific citations to counter each element of the denial. Contrast the insurer's technology assessment with the published guideline evidence. The appeal should argue that the insurer's internal criteria do not reflect the generally accepted standard of medical practice required by the ACA.

Step 6: Request External Independent Review: Complete Guide" class="auto-link">External Review and Invoke Expedited Review if Urgent

For experimental treatment denials, external review is often the most effective remedy — external reviewers overturn these denials at rates exceeding 50 percent in many state programs because they evaluate actual clinical evidence rather than the insurer's cost-driven criteria. If your condition is life-threatening, invoke expedited review: under the ACA, insurers must respond to expedited internal appeals within 24 to 72 hours.

What to Include in Your Appeal

• Insurer's complete technology assessment or medical policy for the treatment
• FDA approval documentation including any supplemental approvals, accelerated approvals, or Breakthrough Therapy Designations
• Peer-reviewed published studies from recognized journals demonstrating safety and efficacy
• Clinical practice guidelines from professional organizations: NCCN, ASCO, AHA, ACS, or the relevant specialty society, with evidence grade noted
• NCCN Drugs and Biologics Compendium listing if applicable to your treatment
• Treating physician's detailed letter explaining why the treatment is medically appropriate, citing clinical evidence and their professional credentials
• Documentation of all prior treatments tried and failed
• For state mandate states: copy of the applicable state law or insurance department guidance

Fight Back With ClaimBack

Being told your treatment is "experimental" when your doctor says it is necessary is one of the most distressing insurance experiences. The experimental label is frequently applied to treatments that are FDA-approved, guideline-supported, and in widespread clinical use — making these denials some of the most successfully challenged on external review. ClaimBack generates a professional appeal letter in 3 minutes that matches your specific treatment to the clinical evidence standards insurers are required to apply.

Start your free claim analysis →

Free analysis · No credit card required · Takes 3 minutes

Related Reading

• How to Write an Insurance Appeal Letter
• What Is Medical Necessity?
• Internal vs External Insurance Appeal